Finanzas de Picard Medical Inc (PMI)PMIPicard Medical Inc

Evaluating the bottom line, Picard Medical Inc maintains a gross margin of 20.85%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -156.70%, while the net margin is -191.60%. These profitability ratios, combined with a Return on Equity (ROE) of N/A, provide a clear picture of how effectively PMI converts its operational activities into shareholder value.

In the context of the broader market, PMI competes directly with industry leaders such as NSPR and ACH. With a market capitalization of $20.57M, it holds a significant position in the sector. When comparing efficiency, PMI's gross margin of 20.85% stands against NSPR's -43.70% and ACH's 38.22%. Such benchmarking helps identify whether Picard Medical Inc is trading at a premium or discount relative to its financial performance.

The company has shown a substantial increase in revenue and gross margin, with Q2 2026 gross margin at 20.9%, up from negative 6.0% a year prior. Despite this, net income remains negative, with a loss of $5.7 million in Q2 2026.